![Yong Mu](https://cdn.zonebourse.com/static/resize/768/576//static/images/insiders/unknown.png)
Profilo
Yong Mu worked as an Executive Director at Everpride Biopharmaceutical Co. Ltd.
from 2004 to 2010.
Precedenti posizioni note di Yong Mu
Società | Posizione | Fine |
---|---|---|
Everpride Biopharmaceutical Co. Ltd.
![]() Everpride Biopharmaceutical Co. Ltd. Pharmaceuticals: OtherHealth Technology Everpride Biopharmaceutical Co. Ltd. principal activities are manufacturing and selling of medicines known as 'Plasmin Capsule' and 'Puli Capsule'. Plasmin capsule has the principal effect of resolving blood clots and may be used for treatment of cardiovascular diseases. Puli capsule has the principal effect of treating osteoarthritis. Other activity includes investment holding. Operations are carried out in the People's Republic of China. Everpride Biopharmaceutical Co. Ltd. was incorporated in the Cayman Islands on 1 August 2000 | Direttore/Membro del Consiglio | 22/04/2010 |
Esperienze
Posizioni ricoperte
Relazioni
Relazioni di 1° grado
Aziende connesse in 1º grado
Uomo
Donna
Amministratori
Dirigenti
Società collegate
Aziende private | 1 |
---|---|
Everpride Biopharmaceutical Co. Ltd.
![]() Everpride Biopharmaceutical Co. Ltd. Pharmaceuticals: OtherHealth Technology Everpride Biopharmaceutical Co. Ltd. principal activities are manufacturing and selling of medicines known as 'Plasmin Capsule' and 'Puli Capsule'. Plasmin capsule has the principal effect of resolving blood clots and may be used for treatment of cardiovascular diseases. Puli capsule has the principal effect of treating osteoarthritis. Other activity includes investment holding. Operations are carried out in the People's Republic of China. Everpride Biopharmaceutical Co. Ltd. was incorporated in the Cayman Islands on 1 August 2000 | Health Technology |
- Borsa valori
- Insiders
- Yong Mu